Professor David Andersson
Professor of Neuroscience
Research interests
- Neuroscience
Contact details
Biography
My research is focused on how sensory neurons control pain and nociception. We are particularly interested in two areas that we are convinced will improve our understanding of acute and chronic pain:
1) We are unravelling the mechanisms responsible for chronic pain in fibromyalgia, complex regional pain syndrome (CRPS), and pain caused by the chemotherapeutic drug oxaliplatin.
2) We are exploring interactions between TRP ion channels and neuronal G-protein coupled receptors and we have demonstrated that these interactions can exert powerful influence over the activity of sensory neurons, thereby controlling pain.
In 2009, I was awarded the first KCL/London Law Trust Medal and fellowship (now the Professor Anthony Mellows Medal).
Please see my Research Staff Profile for more detail
Key publications:
- Andersson et al., 2011. TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Delta(9)-tetrahydrocannabiorcol. Nature Communications.
- Peier et al., 2002. A heat-sensitive TRP channel expressed in keratinocytes. Science.
- Zygmunt et al., 1999. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature.
Key collaborators:
- Professor Stuart Bevan, King's College London
- Dr Andreas Goebel, University of Liverpool
- Professor Camilla Svensson, Karolinska Institute
- Dr Emanuele Sher, Eli Lilly
Research
Clinical Diagnostics Development Unit (CDDU)
The CDDU ethos is to harmonise all methods used within the labs for the processing of clinical samples.
News
Dr David Andersson awarded the Sir Jules Thorn Award for Biomedical Research
The Sir Jules Thorn Charitable Trust has granted £1,699,572 to fund the project 'Novel Diagnostic and Therapeutic Insights for Fibromyalgia'.
New study shows Fibromyalgia likely the result of autoimmune problems
The King's-led study, in collaboration with University of Liverpool and the Karolinska Institute, shows that many of the symptoms in fibromyalgia syndrome are...
Events
Demystifying Impact
This event is an opportunity to hear from others on their journey toward research impact, with sessions on how to maximise your own impact.
Please note: this event has passed.
Features
Celebrating Neuroscience Research this Brain Awareness Week
This year, Brain Awareness Week was held from 14 to 22 March 2022. Brain Awareness Week is the global campaign to foster public enthusiasm and support for...
Research
Clinical Diagnostics Development Unit (CDDU)
The CDDU ethos is to harmonise all methods used within the labs for the processing of clinical samples.
News
Dr David Andersson awarded the Sir Jules Thorn Award for Biomedical Research
The Sir Jules Thorn Charitable Trust has granted £1,699,572 to fund the project 'Novel Diagnostic and Therapeutic Insights for Fibromyalgia'.
New study shows Fibromyalgia likely the result of autoimmune problems
The King's-led study, in collaboration with University of Liverpool and the Karolinska Institute, shows that many of the symptoms in fibromyalgia syndrome are...
Events
Demystifying Impact
This event is an opportunity to hear from others on their journey toward research impact, with sessions on how to maximise your own impact.
Please note: this event has passed.
Features
Celebrating Neuroscience Research this Brain Awareness Week
This year, Brain Awareness Week was held from 14 to 22 March 2022. Brain Awareness Week is the global campaign to foster public enthusiasm and support for...